
































Gender differences relative to smoking behavior and
emissions of toxins from mainstream cigarette smoke
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This study examined whether gender differences exist in the exposure to select mainstream cigarette smoke toxins
as a result of differences in smoking behavior or type of cigarettes smoked among 129 female and 128 male
smokers. Smoking topography data indicated that, compared with men, women took smaller puffs (37.6 ml/puff vs.
45.8 ml/puff; p5.0001) of shorter duration (1.33 s/puff vs. 1.48 s/puff; p5.002) but drew more puffs per cigarette
(13.5 vs. 12.0; p5.001) and left longer butts (36.3 mm or 40.2% of cigarette length vs. 34.3 mm or 39.2% of
cigarette length; p5.01). These trends were similar in both African Americans and European Americans. The
emissions of select toxins per cigarette, as determined by mimicking human smoking behaviors were greater among
the male smokers than the female smokers and correlated significantly with delivered smoke volume per cigarette.
The geometric means of emissions of nicotine from cigarettes were 1.92 mg/cigarette (95% CI51.80–2.05) for
women versus 2.20 (95% CI52.04–2.37) for men (p5.005). Cigarettes smoked by women yielded 139.5 ng/
cigarette of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK; 95% CI5128.8–151.0), compared with
170.3 ng/cigarette (95% CI5156.3–185.6) for men (p5.0007); benzo(a)pyrene (BaP) emissions were 18.0 ng/
cigarette (95% CI517.0–19.0) for women and 20.5 ng/cigarette (95% CI518.8–22.3) for men (p5.01). The gender
differences with regard to cigarette smoke yields of toxins were more profound in European Americans than in
African Americans. On average, African American men’s smoking habits produced the highest emissions of select
toxins from cigarettes, and European American female smokers had the lowest exposure to carcinogens and toxins.
Several studies have suggested that women may be more susceptible than men to the ill effects of carcinogens in
tobacco and tobacco smoke, whereas other studies have not found differences in lung cancer risk between men and
women. The present study suggests that gender differences in exposure to tobacco smoke cannot account for a
higher rate of lung cancer in female smokers compared with male smokers.
Introduction
Lung cancer currently accounts for 12.7% of all
cancers diagnosed in the United States and for 28.5%
of all cancer deaths (Jamal et al., 2004). According to
the 2001 report of the U.S. surgeon general, lung
cancer has surpassed breast cancer as the foremost
cause of cancer deaths among women (U.S.
Department of Health and Human Services
[USDHHS], 2001). Lung cancer mortality increased
sixfold among White women in the United States
between 1950 and 1997 (USDHHS, 2001), but lung
cancer mortality in women has reached a plateau
after many decades of increase (Jamal et al., 2004).
Several studies implied that women who smoke
may be more susceptible to lung cancer than are male
smokers (Gasperino & Rom, 2004; Risch et al., 1993;
Zang & Wynder, 1996). Other case–control studies
and prospective data, however, have not found
differences in lung cancer risk between men and
women (Engeland, Andersen, Haldorsen, & Tretli,
1996; Freund, Belanger, D’Agostino, & Kannel,
1993; Kreuzer et al., 2000; Marang-van de Mheen,
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Smith, Hart, & Hole, 2001; Nordlund, Carstensen, &
Pershagen, 1999; Prescott et al., 1998; Simonato et al.,
2001; Twombly, 2004). To address this controversy,
Bain et al. (2004) analyzed prospective data from
former and current smokers in two large cohorts, the
Nurses’ Health Study of 60,296 women and the
Health Professionals follow-up study of 25,397 men.
After adjusting for age, number of cigarettes smoked
per day, age at onset of smoking, and time since
quitting, the researchers found that women do not
appear to have a greater susceptibility toward lung
cancer than men, given equal exposure to cigarette
smoke. However, analyses by histologic type of lung
cancer showed that female smokers had a signifi-
cantly higher rate of adenocarcinoma but a lower
risk of large-cell lung cancer, compared with men
(Bain et al., 2004; Brownson, Chang, & Davis, 1992;
Khuder, 2001; Koyi, Hillerdal, & Branden, 2002;
Thun et al., 1997). Although Bain et al. (2004)
suggest that no gender-based difference exists for risk
of lung cancer among smokers, some differences
likely exist in the way women and men smoke their
cigarettes, in the type of cigarettes they use, and in
the way they metabolize smoke carcinogens. Two
people may smoke the same brand of cigarette but
inhale different doses of carcinogens and toxins due
to their specific smoking behavior; thus, they may be
exposed to different levels of DNA-damaging agents.
If men and women have the same cancer incidence
rates and men inhale more carcinogens per cigarette
than women, or if differences in metabolism exist,
then this analysis may underestimate differences in
susceptibility to cancer.
The study we report here compared smoking
behavior and emissions of select toxins from cigar-
ettes customarily smoked by men and women. The
smoking topography (puff volume, duration, inter-
puff intervals, and frequency) along with blocking
ventilation holes of filter tips and butt length for 129
female and 128 male cigarette smokers was deter-
mined using a pressure transducer system. Each
smoker’s brand and type of cigarette was then
machine-smoked under conditions matching the
habits of the corresponding participant in the study.
The smoke particulates were analyzed for select
carcinogens and toxic agents to determine whether
the men and women had quantitatively different
exposure to cigarette smoke carcinogens.
Method
Subject recruitment and procedures
This study was approved by the American Health
Foundation’s Human Subjects Review Committee. A
total of 257 smokers of different types of cigarettes
were recruited, through newspaper advertisements in
Westchester County, New York, in 1996–1998 (130
smokers) and 2001–2003 (127 smokers). These
volunteers, who were between 18 and 59 years of
age, were interviewed by telephone to determine
whether they met the following specific inclusion
criteria: They had to have smoked at least 10
cigarettes of their current brand daily for at least 1
year, and they had to be in good health, without a
history of any tobacco-related disease and without
any unstable medical condition. They also had to be
free from psychotropic medications and without any
psychiatric diagnosis at the time of the study. They
were not eligible if they were using smokeless tobacco
or other nicotine containing products. Pregnant or
nursing women were excluded from the study. Those
who were enrolled were informed about all aspects of
the study, its goals, and its procedures.
Subjects who met the inclusion criteria were asked
to collect cigarette butts for a total of 4 days prior to
their visit to the American Health Foundation and to
bring the butts to the laboratory. A package
including detailed instructions for collection of
cigarette butts and plastic bags for storage of butts
was mailed to each volunteer. The butts were used to
validate the subject’s self-reported number of cigar-
ettes smoked per day, to measure the average length
of each cigarette smoked, and to evaluate whether
blocking of the air vents of filter tips typically
occurred during smoking. At the initial visit, each
participant was interviewed by a trained interviewer.
The Fagerstro¨m Test for Nicotine Dependence was
used to determine an index of nicotine dependence
(Heatherton, Kozlowski, Frecker, & Fagerstro¨m,
1991). Volunteers were also administered American
Health Foundation’s comprehensive questionnaire to
obtain information on smoking history, namely, the
age at onset of smoking, quantity of cigarettes and
number of years smoked, occupational exposure,
family medical history, diet, and other lifestyle
factors. During the interview, volunteers disclosed
the brand of cigarettes they smoke, including
cigarette size, type of pack (hard or soft), and
whether they smoked menthol or nonmenthol cigar-
ettes. Detailed cigarette brand information was
required to assign the correct Federal Trade
Commission (FTC) smoke yield because several
varieties with different FTC machine-smoking yields
are marketed under the same brand name. All eligible
participants signed a written consent statement at
enrollment in the study.
Smoking topography measurements
The volunteers’ smoking topography (puff volume,
duration, interpuff intervals, and frequency) was
measured with a tobacco smoke testing system
manufactured at the University of Kentucky

































(Lexington). A detailed description of this puff
analyzer was reported previously (Djordjevic, Fan,
Ferguson, & Hoffmann, 1995). This system calcu-
lates and stores values for each puff for its volume,
duration, interpuff interval, and the total number of
puffs per cigarette (Djordjevic et al., 1995; Puustinen,
Olkkonen, Kolonen, & Tuomisto, 1987). Data from
all puffs of each cigarette were used to determine the
average puff volume, puff duration, and interpuff
intervals. The smoking topography of each person
was tested twice to ensure the reproducibility of the
assay. The time elapsed between two cigarettes
smoked was at least a half-hour. Volunteers whose
smoking parameters deviated by more than 15%
between the first and second cigarettes were asked to
smoke a third cigarette after a one-half-hour or
longer time interval. If the smoking parameters for
the third cigarette differed significantly from the
others, the subject was excluded from the study (five
subjects were excluded because of a deviance in
topography measurement). Most smoking measure-
ments were carried out between 10:00 A.M. and 1:00
P.M.
The levels of exhaled carbon monoxide (CO) in
expired breath were measured with the Vitalograph
Breath CO analyzer (Vitalograph Inc., Lenexa,
Kansas) immediately after the cigarette was extin-
guished, and again 10 min later. This procedure was
carried out first when volunteers smoked freely
without a testing device in a smoking-designated
area in our institute and then again when they used
the tobacco smoke testing system adapter in the
laboratory setting. The cigarette holder of the puff
analyzer does not block the filter vents in the way
that smokers do. Thus, degree of filter vent blocking
was estimated from the smokers’ cigarette butts (see
below). Then the filter vents of cigarettes were
covered with tape (to simulate each smoker’s habit)
before topography measurements were taken.
The degree of blocking of filter vents was assessed
by observation using the so-called bull’s-eye method
(Djordjevic, Stellman, & Zang, 2000; Kozlowski,
Pope, & Lux, 1988), in which the circular pattern of
the tar stain is viewed at the end of the filter tip. A
completely stained surface indicates complete block-
ing; a smaller circular stain at the center of the filter
tip, surrounded by a white periphery (the bull’s eye)
indicates no blocking; and incomplete staining of
the peripheral circle indicates partial blocking
(generally less than 50% of ventilation holes were
blocked).
Measurements of emission of mainstream cigarette
smoke toxins
Chemicals. [2H12]-benzo(a)pyrene (BaP) was obtained
from Cambridge Isotope Laboratories (Andover,
Massachusetts). Tobacco-specific nitrosamines
(TSNA) analytical standards, namely N9-nitrosonor-
nicotine (NNN), 4-(methylnitrosamino)-1-(3-pyridyl)-
1-butanone (NNK), N-nitrosoanatabine (NAT), and
N-nitrosoanabasine (NAB) were purchased from
Toronto Research Chemicals (Ontario, Canada). N-
nitrosoguvacoline was synthesized at the American
Health Foundation’s Organic Synthesis Laboratory.
Machine smoking of cigarettes. For each subject the
average smoking parameters were determined from
recordings of two cigarettes smoked through the
puff analyzer. These parameters were then pro-
grammed into a one-channel, piston-type smoking
machine (Borgwaldt, Germany; Djordjevic et al.,
1995; Djordjevic et al., 2000). Each individual’s
brand of cigarette was conditioned for 24 hr at room
temperature in a 55%–65% relative humidity cham-
ber and then machine-smoked with his or her
average smoking parameters, including blocking of
the filter tip vents, and specific butt length. For the
determination of each analyte the smoke particu-
lates from four cigarettes were collected on 44-mm
Cambridge filter pads. To quantify the TSNAs,
filter pads were first treated with 2 ml of 2% ascorbic
acid in methanol solution and were air-dried in a
chemical fume hood before the collection of smoke
particulates.
Determination of BaP in mainstream smoke
emissions. Cigarette smoke condensate (particulate
matter) collected from four cigarettes on a Cambridge
filter was placed in a 20-ml scintillation vial and 80ml
of 1mg/ml [2H12]BaP in benzene was added as an
internal standard, prior to extraction with 3610 ml
CH2Cl2. After each addition of CH2Cl2, the vials
containing the filters were placed into an ultrasonic
bath for 30 min. The three CH2Cl2 extracts were
combined and the solvent was removed under vacuum
using a Speedvac. The dry residue was dissolved in
500ml of CH2Cl2. A 100-ml aliquot of extract was
applied to a 250-mg Bakerbond column prewashed
with CH2Cl2. This column was eluted with 36200ml
CH2Cl2. BaP eluates (2ml) from the column were
analyzed by gas chromatography–negative chemical
ionization–selected ion monitoring–mass spectrome-
try (GC-NCI-SIM-MS) as described previously
(Melikian et al., 1999). The GC-MS analysis was
performed on a Hewlett Packard (HP) 5973 mass
spectrometer coupled to a HP 6890 gas chromato-
graph (Wilmington, Delaware) using a ZB-5
(60 m60.25 mm i.d.60.25mm film thickness) capil-
lary column (Phenomenex, Torrance, California). The
gas chromatograph oven temperature was held at
60uC for 3 min, then programmed to rise to 200uC at
increments of 25uC/min, followed by 10uC/min to
310uC. Under this condition, BaP is separated from
benzo(e)pyrene (BeP), which has a similar molecular

































ion. The mass spectral conditions were as follows: Ion
source, 150uC; emission current, 250mA; electron
energy, 110 eV. The ions monitored were at m/
z5252 for BaP and at m/z5264 for the internal
standard [2H12]BaP.
Determination of tobacco-specific nitrosamines in
mainstream smoke emissions. The analysis of TSNA
was carried out by a method described previously
(Adams, Brunnemann, & Hoffmann, 1983;
Brunnemann & Hoffmann, 1991). In brief, cigarette
smoke particulate matter collected from four cigar-
ettes on a Cambridge filter pretreated with ascorbic
acid was extracted with 3615 ml CH2Cl2. Pooled
CH2Cl2 extracts were chromatographed on a 15-g
basic alumina column (activity II-III; Woelm,
Germany). The TSNA fraction was dried and, after
the addition of 100ml of 20mg/ml N-nitrosoguvaco-
line as a chromatographic standard, was analyzed by
gas chromatography–thermal energy analysis (GC-
TEA). The GC-TEA analysis was carried out with an
HP Model 5890 gas chromatograph interface with a
thermal energy analyzer model 610 (Thermal Energy
Corporation, Waltham, Massachusetts). Gas chro-
matographic analyses were performed on a DB-5
fused silica capillary column (6060.32 mm, 0.25-m
film thickness; Altech, Deerfield, Illinois). The gas
chromatograph injection port temperature was
220uC and oven temperature was held at 80uC for
5 min, then programmed to rise to 140uC at incre-
ments of 30uC/min, then held for 5 min, followed by
an increase at 30uC/min to 200uC and then held for
15 min. The carrier gas was helium at a flow rate of
3 ml/min.
Determination of nicotine. Nicotine was quantified
by a GC method reported previously (Djordjevic
et al., 2000).
Data analyses
Outcome parameters (smoking characteristics, puff
profiles, cigarette smoke emissions, and the like) were
compared between men and women using t-tests and
analysis of covariance models to adjust for race and
other covariates, such as body mass index. Due to the
nonnormal distribution of outcomes, these variables
were log-transformed and are presented here as
geometric means with 95% confidence intervals.
Tests were considered statistically significant at a p
level of less than .05.
Results
Comparison of demographic characteristics among
female and male smokers
The demographic characteristics of female (n5129;
44% African American) and male (n5128; 43%
African American) smokers who participated in this
study are summarized in Table 1. We found no
significant differences regarding age, nicotine depen-
dence, and years smoked between men and women
Table 1. Comparison of smoking characteristic between women and men volunteers.
Variable
Women Men
p valueGeometric mean (95% CI) Geometric mean (95% CI)
All subjects
Number of subjects n5129 n5128
Age (years) 33.1 (31.2–35.0) 35.0 (33.3–36.9) .14
Body mass index 25.5 (24.5–26.5) 26.8 (26.1–27.4) .06
Cigarettes per day (self-reported) 15.9 (14.7–17.1) 16.8 (15.5–18.2) .42
Age at onset of smoking (years) 15.3 (14.7–15.8) 16.4 (15.8–17.0) .008
Years smoked 14.9 (13.2–16.9) 15.8 (14.0–17.9) .44
Fagerstro¨m index 4.11 (3.65–4.62) 4.57 (4.12–5.06) .23
African Americans
Number of subjects n557 n555
Age (years) 34.4 (31.8–37.3) 36.4 (34.0–39.1) .29
Body mass index 27.6 (26.0–29.4) 27.3 (26.2–28.4) .74
Cigarettes per day (self-reported) 14.3 (12.8–16.0) 14.1 (12.8–15.6) .83
Age at onset of smoking (years) 15.8 (14.8–16.8) 16.6 (15.8–17.5) .2
Years smoked 15.7 (13.2–18.5) 17.4 (14.9–20.4) .37
Fagerstro¨m index 4.12 (3.49–4.89) 4.28 (3.69–4.93) .78
European Americans
Number of subjects n572 n573
Age (years) 32.1 (29.6–34.8) 34.1 (31.7–36.6) .28
Body mass index 24.0 (22.9–25.1) 26.4 (25.6–27.2) .0007
Cigarettes per day (self-reported) 17.2 (15.6–19.0) 19.1 (17.1–21.4) .17
Age at onset of smoking (years) 14.9 (14.3–15.5) 16.3 (15.5–17.1) .009
Years smoked 14.3 (12.0–17.1) 14.8 (12.4–17.6) .81
Fagerstro¨m index 4.09 (3.46–4.80) 4.80 (4.16–5.52) .15
Note. The p values were calculated using Student’s t-test.

































within either group, African American or European
American. The age at onset of smoking was
significantly lower for the European American
women than for the European American men (14.9
years vs. 16.3 years; p5.009), but we found no
significant gender difference at onset of smoking
among African Americans (15.8 years in women vs.
16.6 years in men; p5.2). European American
women had significantly lower body mass index than
did European American men (24.0 vs. 26.4;
p5.0007). We found no body mass index difference
between African American women versus men (27.6
vs. 27.3; p5.74).
Self-reported data for smoking intensity were used
for all calculations in this study because the self-
reported number of cigarettes smoked per day and
counts of cigarette butts collected over 4 days were
significantly correlated (r5.97, n5196, p,.0001). In
addition, Clark, Gautam, Hlaing, and Gerson (1996)
have demonstrated that no significant racial differ-
ence exists in the magnitude of error in self-reporting
smoking frequency.
Exhaled carbon monoxide
We found no significant differences in the level of CO
exhaled when cigarettes were smoked freely or
smoked through the puff analyzer in a laboratory
setting (Table 2). We also found no significant racial
or gender differences in the level of exhaled CO
(Table 2); this finding confirms a previous report that
indicates no gender differences in exhaled CO
(Zeman, Hiraki, & Sellers, 2002). The CO measure-
ment merely indicates that a correlation exists
between free smoking and smoking with a cigarette
placed in the transducer (r5.83) but does not
definitively prove the smoking patterns are similar.
Gender differences in smoking topography and type or
brand of cigarettes smoked
Table 3A compares smoking topography among
female and male smokers for all subjects; Table 3B
describes gender differences in smoking topography
among African Americans and European Americans.
In general, women took smaller puffs (M537.6 ml)
than men (M545.8 ml; p5.0001). The puff duration
also was shorter for women (M51.33 s/puff) than for
men (M51.48 s/puff; p5.002). The average number
of puffs per cigarette was greater for women
(M513.5) than for men (M512.0; p5.001). These
trends were similar in both African American and
European American smokers. Average smoke uptake
from each cigarette was 507.8 ml for women and
553.0 ml for men (the difference was not statistically
significant, p5.06). Another gender difference in
smoking habits was that European American women
left significantly longer cigarette butts (mean
length537.8 mm, or 42.3% of the length of cigarette),
compared with European American men (mean
length534.6 mm, or 40.0% of the length of cigarette;
p5.0006. Among African Americans, the average
butt length left by female smokers was 34.5 mm
(37.5% of the length of cigarette), compared with
33.9 mm for men (38.0% length of the cigarette),
p5.93.
We found a gender difference in the type of
cigarettes smoked by European American smokers,
whereas both African American men and women
smoked similar cigarettes (Tables 3B and 4B).
Among European Americans, women smoked cigar-
ettes with relatively low machine-smoked (FTC)
yields of CO, nicotine, and tar. Among African
Americans, 87% of the women and 81% of the men
smoked mentholated cigarettes for which FTC yields
of nicotine, CO, and tar were similar.
Table 2. Levels of exhaled carbon monoxide (CO) when cigarettes were smoked in a conventional free environment and when
cigarettes were smoked through a puff analyzer in a laboratory setting.



















Number of subjects n559 n571 n559 n574
CO (ppm) after smoking in
free environmenta
24.63¡1.85* 21.66¡1.55** .11 22.64¡1.85* 23.12¡1.27** .81
CO* (ppm) after smoking in
laboratory settinga
25.38¡1.38*** 22.44¡1.15**** .10 22.99¡1.85*** 23.69¡1.20**** .72
p-value (CO laboratory
smoking vs. free smoking)b
.713 .632 .875 .747
Note. aMeans of exhaled CO immediately and 10 min after smoking cigarette. bTwo-tailed paired t-test. *p5.36; **p5.39; ***p5.24;
****p5.40.

































Comparison of emissions of select mainstream smoke
constituents from cigarettes as smoked by women and
by men
Table 4A shows the emissions of selected main-
stream smoke constituents as generated under each
individual’s smoking conditions for all subjects in
this study. Table 4B compares the differences in
emissions of smoke toxins generated by both
African American and European American men
and women. Emissions of carcinogens were sig-
nificantly higher from the cigarettes smoked by
European American males than from those smoked
by women, whereas these differences were not
significant in African Americans, except for NNK
per cigarette. In European Americans, the geo-
metric mean of emitted total particulate matter
(TPM) from a cigarette was 23.8 mg for women
Table 3A. Comparison of smoking topography between women and men volunteers.
Variable, all subjects
Women Men
p valueGeometric mean (95% CI) Geometric mean (95% CI)
Number of subjects n5129 n5128
Puff volume (ml/puff) 37.6 (35.5–39.9) 45.8 (43.2–48.5) .0001
Number of puffs/cigarette 13.5 (12.9–14.1) 12.0 (11.4–12.6) .001
Puff duration (s/puff) 1.33 (1. 27–1.39) 1.48 (1.40–1.56) .002
Puff interval (s/puff) 20.4 (18.9–22.0) 20.7 (19.1–22.6) .33
Total puff volume/cigarette (ml) 507.8 (478.3–539.2) 553.0 (519.7–588.4) .06
Total puff volume/day (L) 8.0. (7.34–8.89) 9.30 (8.35–10.4) .02
Length of cigarette smoked (mm) 54.1 (52.7–55.5) 53.2 (51.7–54.9) .54
Butt length (mm) 36.3 (35.4–37.2) 34.3 (33.4–35.2) .01
Menthol cigarette smokers (percent) 50 50
Filter tip vents absent or blocked (percent) 47 46
Note. The p values were calculated using Student’s t test.
Table 3B. Comparison of smoking topography between women and men volunteers.
Variable
Women Men
p valueGeometric mean (95% CI) Geometric mean (95% CI)
African Americans
Number of subjects n557 n555
Puff volume (ml/puff) 38.6 (35.6–41.8) 47.4 (43.5–51.7) .0008
Number of puffs/cigarette 13.3 (12.4–14.4) 11.6 (10.6–12.7) .04
Puff duration (s/puff) 1.31 (1.23–1.40) 1.53 (1.42–1.64) .003
Puff interval (s/puff) 20.5 (18.3–23.0) 21.5 (19.1–24.2) .36
Total puff volume/cigarette (ml) 515.7 (468.9–567.2) 553.4 (503.2–608.6) .34
Total puff volume/day (L) 7.45 (6.53–8.49) 7.8 (6.75–9.01) .40
Length of cigarette smoked (mm) 57.3 (55.1–59.6) 55.3 (52.8–57.9) .29
Butt length (mm) 34.5 (33.4–35.5) 33.9 (32.4–35.4) .93
Type of cigarette smoked (mean
FTC nicotine yield/cigarette)
0% UL 0% UL
15.5% L (0.72 mg/cig) 10.4% L (0.78 mg/cig)
43.1% M (1.17 mg/cig) 48.2% M (1.13 mg/cig)
41.4 H (1.4 mg/cig) 41.4% H (1.4 mg/cig)
87% Menthol (1.2 mg/cig) 81% Menthol (1.2 mg/cig)
European Americans
Number of subjects n572 n573
Puff volume (ml/puff) 36.9 (34.0–40.1) 44.7 (41.3–48.3) .001
Number of puffs/cigarette 13.6 (12.8–14.4) 12.3 (11.5–13.0) .01
Puff duration (s/puff) 1.34 (1.25–1.44) 1.44 (1.33–1.56) .10
Puff interval (s/puff) 20.2 (18.2–22.5) 20.2 (17.9–22.7) .62
Total puff volume/cigarette (ml) 501.7 (464.5–541.9) 552.7 (508.9–600.3) .07
Total puff volume/day (L) 8.61 (7.53–9.85) 10.6 (9.1–12.3) .02
Length of cigarette smoked (mm) 51.7 (50.1–53.4) 51.8 (49.9–53.9) .84
Butt length (mm) 37.8 (36.5–39.1) 34.6 (33.4–35.8) .0006
Type of cigarette smoked
(mean FTC nicotine yield/cigarette)
2.8% UL (0.4 mg/cig) 4.1% UL (0.2 mg/cig)
57.8% L (0.68 mg/cig) 34.3% L (0.74 mg/cig)
36.6% M (1.07 mg/cig) 43.8% M (1.1 mg/cig)
2.8% H (1.4 mg/cig) 17.8% H (1.47 mg/cig)
21.1% Menthol (1.0 mg/cig) 27.4% Menthol (1.1 mg/cig)
Note. UL5ultra light (,0.5 mg nicotine/cig); L5light (0.5–0.8 mg nicotine/cig); M5medium (0.9–1.2 mg nicotine/cig); H5high yield
(>1.3 mg nicotine/cig). The p values were calculated using Student’s t test.

































versus 33.2 mg for men (p5.0002), and the released
nicotine per cigarette was 1.63 mg for women
versus 2.02 mg for men (p5.004). The BaP yield
generated was 16.3 ng/cigarette for women versus
18.9 ng/cigarette for men (p5.04). Finally, NNK
emission from cigarettes was 137.1 ng/cigarette for
women versus 166.7 ng/cigarette for men (p5.02;
Table 4B).
Relationships of inhaled cigarette smoke and measured
emissions of toxic compounds from cigarettes as
smoked by men and women
Figures 1A–D show the relationships of total cigar-
ette smoke intake by mouth and emissions of select
toxins as determined in cigarettes smoked by men
and women. We observed large interindividual
Table 4A. Comparison of emissions of mainstream smoke toxins from cigarettes smoked by all women and men.
Variable, all subjects
Women Men
p valueGeometric mean (95% CI) Geometric mean (95% CI)
Number of subjects n5127 n5126
FTC carbon monoxide/cig (mg) 12.6 (11.9–13.3) 13.6 (12.8–14.5) .05
FTC nicotine/cig (mg) 0.94 (0.89–1.00) 1.03 (0.96–1.1) .06
FTC tar/cig (mg) 12.2 (11.3–13.1) 13.8 (12.7–14.9) .02
HSC nicotine/cig (mg) 1.92 (1.80–2.05) 2.2 (2.04–2.37) .005
HSC nicotine/FTC nicotine 2.04 2.14
HSC TPM/cig (mg) 29.3 (26.9–31.8) 37.0 (33.9–40.5) .0001
HSC BaP/cig (ng) 18.0 (17.0–19.0) 20.5 (18.8–22.3) .01
HSC TSNA/cig (ng) 657.4 (608.2–710.5) 770.9 (712.8–833.8) .005
HSC NNK/cig (ng) 139.5 (128.8–151.0) 170.3 (156.3–185.6) .0007
HSC BaP/day (ng) 283.8 (257.7–312.5) 344.0 (306.3–386.3) .02
HSC nicotine/day (mg) 30.3 (27.3–33.6) 37.0 (33.2–41.2) .02
HSC NNK/day (mg) 2.2 (1.97–2.47) 2.86 (2.53–3.24) .004
Note. HSC5human smoking condition; FTC5Federal Trade Commission–specified machine-smoking protocol (35-ml puff volume
drawn for 2 s once per minute). The p values were adjusted for body mass index using analysis of covariance models.




p valueGeometric mean (95% CI) Geometric mean (95% CI)
African Americans
Number of subjects n556 n553
FTC carbon monoxide/cig (mg) 15.4 (14.5–16.4) 15.5 (14.9–16.2) .85
FTC nicotine/cig (mg) 1.17 (1.10–1.24) 1.17 (1.12–1.23) .92
FTC tar/cig (mg) 15.5 (14.4–16.7) 15.9 (15.0–16.8) .64
HSC nicotine/cig (mg) 2.34 (2.16–2.55) 2.48 (2.24–2.75) .37
HSC nicotine/FTC nicotine 2.0 2.12
HSC TPM/cig (mg) 37.6 (33.7–41.9) 43.2 (38.5–48.5) .08
HSC BaP/cig (ng) 20.2 (18.8–21.7) 22.8 (20.3–25.7) .09
HSC TSNA/cig (ng) 705.5 (632.4–787.0) 819.0 (736.7–910.6) .05
HSC NNK/cig (ng) 142.4 (126.2–160.7) 175.4 (154.6–199.0) .02
HSC BaP/day (ng) 288.9 (252.2–330.9) 320.4 (273.6–375.1) .42
HSC nicotine/day (mg) 33.6 (29.2–38.6) 34.8 (30.2–40.2) .77
HSC NNK/day (mg) 2.04 (1.71–2.43) 2.46 (2.09–2.91) .16
European Americans
Number of subjects n571 n573
FTC carbon monoxide/cig (mg) 10.7 (9.9–11.4) 12.4 (11.2–13.6) .03
FTC nicotine/cig (mg) 0.80 (0.74–0.86) 0.93 (0.84–1.04) .03
FTC tar/cig (mg) 10.1 (9.2–11.0) 12.4 (10.9–14.10) .02
HSC nicotine/cig (mg) 1.63 (1.51–1.76) 2.02 (1.83–2.23) .004
HSC nicotine/FTC nicotine 2.04 2.17
HSC TPM/cig (mg) 23.8 (21.5–26.4) 33.2 (29.4–37.5) .0002
HSC BaP/cig (ng) 16.3 (15.1–17.6) 18.9 (16.8–21.3) .04
HSC TSNA/cig (ng) 620.1 (556.6–691.0) 736.7 (659.1–823.4) .04
HSC NNK/cig (ng) 137.1 (123.3–152.5) 166.7 (148.3–187.5) .02
HSC BaP/day (ng) 279.7 (244.1–320.5) 361.8 (307.1–426.3) .03
HSC nicotine/day (mg) 27.9 (24.0–32.3) 38.6 (33.0–45.1) .01
HSC NNK/day (mg) 2.35 (2.02–2.73) 3.19 (2.68–3.80) .01
Note. HSC5human smoking condition; FTC5Federal Trade Commission-specified machine-smoking protocol (35-ml puff volume
drawn for 2 s once per minute). The p values were adjusted for body mass index using analysis of covariance models.

































variations in volume of smoke uptake both by
women and by men. Total puff volume among
women varied from 199 ml to 1,144 ml per cigarette
with a median of 514 ml; among men, corresponding
values ranged from 239 ml to 1,364 ml, with a median
of 558 ml. Similarly, we observed large interindivi-
dual variations of emissions of toxins from cigarettes
smoked by women and by men primarily due to
differences from cigarette to cigarette, and also due
to the way they were smoked (e.g., blocking filter
vents) and butt length. Variations of emissions of
TPM from cigarettes as smoked by women ranged
from 9.8 mg to 88.4 mg per cigarette with a median of
28.8 mg/cigarette; when smoked by men, they ranged
from 7.1 mg to 112 mg per cigarette with a median of
39.9 mg/cigarette. Corresponding values for nicotine
ranged from 0.8 mg to 4.9 mg per cigarette with a
median of 1.9 mg/cigarette for women, and from
0.6 mg to 5.6 mg per cigarette for men with a median
of 2.3 mg/cigarette. Emissions of NNK per cigarette
varied from 61 ng to 445 ng with a median of 126 ng
for women, and from 53 ng to 714 ng with a median
of 177 ng for men. Corresponding values for BaP in
cigarette smoke ranged from 6.3 ng to 37.8 ng per
cigarette with a median of 18.1 ng/cigarette for
women, and from 5.9 ng to 63.1 ng per cigarette with
a median of 20.9 ng/cigarette for men.
Interindividual variations in emissions of nicotine from
a U.S. popular cigarette due to smoking behavior
Figure 2 shows interindividual variations in emis-
sions from a popular U.S. brand of cigarette
(nonmentholated, 1.1 mg FTC nicotine/cigarette)
when machine-smoked mimicking the smoking para-
meters of 40 smokers. The emissions of nicotine
ranged from 1.1 mg to 4.3 mg per cigarette. On
average, human smoking behavior produced about
2.4-fold greater nicotine values than did the machine-
smoking with the FTC standard protocol.
Figure 1. Correlations between total smoke intake per cigarette and emissions of various tobacco smoke toxins: (A)
total particulate matter (TPM), (B) NNK, (C) nicotine, and (D) benzo(a)pyrene (BaP) in female and male smokers. HSC,
human smoking conditions.
Figure 2. Interindividual variations in uptake of nicotine
by smokers who smoke the same popular U.S. brand of
cigarette (FTC nicotine51.1 mg/cigarette). HSC, human
smoking conditions.


































The type or brand of cigarette and the way each
cigarette is smoked by an individual affect main-
stream smoke yields and, thus, human exposure to
harmful compounds. Gender, race, cigarette type,
and total number of cigarettes smoked also may
affect metabolism of tobacco smoke toxins and,
consequently, the exposure to metabolites that are
ultimate carcinogens. The study described here
examined how differences in smoking behavior
(smoking topography) and the type of cigarettes
smoked affected the emissions of select toxins from
cigarettes smoked by European American and
African American women and men. The factors that
influence the metabolism of tobacco smoke carcino-
gens in those smokers are also important and will be
presented in a separate paper.
The smoking topography measurements confirmed
that puffing patterns of the female smokers differed
significantly from those of the male smokers
(Eissenberg, Adams, Riggins, & Likness, 1999).
Women took smaller puffs of shorter duration than
did men, but they took more puffs per cigarette than
the men (Table 3A). European American women left
significantly longer cigarette butts than did European
American men, but the same finding was not
observed among African Americans. By leaving
longer cigarette butt lengths, European American
women may slightly reduce their exposure to poly-
cyclic aromatic hydrocarbons and nicotine in com-
parison with other groups, since the smoke yields of
TPM, BaP, and nicotine increase with ascending
puffs (Melikian & Djordjevic, 2004).
Cigarettes smoked by women emitted lower
amounts of select carcinogens and nicotine than the
cigarettes smoked by men (Table 4A), and this
difference was more profound among European
American smokers. On average, African American
men’s smoking habits produced the highest emissions
of select toxins from cigarettes, and European
American female smokers had the lowest exposure
to carcinogens and toxins (Table 4B). These differ-
ences can be attributed primarily to different types of
cigarettes smoked. European Americans, especially
women, smoked cigarettes with relatively lower
machine-smoked yields (FTC yields) than did
African Americans (Table 3A and 3B). European
Americans also smoked cigarettes with ventilated
filter tips, and most of them did not block the
ventilation holes during smoking. African
Americans, on the other hand, smoked primarily
cigarettes that contained menthol and did not have
filter vents.
Studies conducted to date have found that
increases in puff volume, decreases in time between
puffs, and intentional blocking of filter ventilation
each produce significant increases in smoke yields;
the latter also alters smoke composition (Borgerding
& Klus, 2005). Gender differences in smoking
behavior may affect the smoke yields and composi-
tion of carcinogenic agents in cigarette smoke. To
assess the influence of an individual’s smoking
behavior on exposure to cigarette smoke toxins, we
compared interindividual variations in emissions
(yields) of nicotine from a popular U.S. cigarette as
smoked by a small subgroup of 40 smokers
(Figure 2). We found a large interindividual variation
in nicotine yields, ranging from 1.1 mg to 4.3 mg
nicotine per cigarette. On average, the human
smoking behavior produced about 2.4-fold greater
nicotine values than did the machine-smoking with
the FTC standard protocol (35-ml puff volume
drawn for 2 s once per minute). When cigarettes
were machine-smoked under the conditions observed
in the female and male test groups in the present
study, nicotine yields were about 2- to 2.17-fold
higher than the emissions recorded when the cigar-
ettes were smoked under the FTC machine-smoking
protocol (Tables 4A and 4B). This finding confirms
that the FTC protocol underestimates the intake of
nicotine and carcinogens by smokers (Djordjevic
et al., 2000; Jarvis, Boreham, Primatesta, &
Feyerabend, 2001; Ueda et al. 2002).
Fischer, Spiegelhalder, and Preussmann (1989)
have shown that, among the smoking parameters,
puff volume and puff frequency have a significant
influence on the TSNA yields in mainstream smoke.
We found that the emissions of TPM, nicotine, BaP,
and NNK also correlate strongly with the total puff
volume of smoke generated per cigarette both in
male and female smokers (Figure 1). The correlations
between smoke per cigarette and emissions of
individual toxins were stronger for the cigarettes
smoked by men than by women. The slopes of linear
regression lines of the plotted emissions of BaP,
TPM, and nicotine against total smoke intake were
steeper for the cigarettes smoked by men than for
those smoked by women. This was especially so for
BaP, but no gender difference was seen in exposure
to NNK (Figure 1). The significantly higher emis-
sions of BaP from cigarettes smoked by men could be
related partially to the fact that men take larger puffs
than women. Taking larger puffs may decrease air
velocity in comparison with smaller puffs for the
same total volume of smoke, which may provide for
less complete combustion and thus somewhat higher
polycyclic aromatic hydrocarbons (BaP) formation.
In addition, men smoked their cigarettes down to a
shorter butt length and used brands that give higher
smoke yields when smoked under FTC standard
conditions.
Adenocarcinoma of the lung is the histologic type
observed more often in women (62%) than in men
(41%; Bain et al., 2004; Brownson et al., 1992;

































Khuder, 2001; Koyi et al., 2002; Thun et al., 1997).
Cigarette smoke contains several classes of carcino-
gens, among which polycyclic aromatic hydrocar-
bons and TSNAs have been studied extensively. A
tobacco-specific carcinogen, NNK, is a lung carcino-
gen in laboratory animals (Hecht, 1998). NNK also
was recognized by the International Agency for
Research on Cancer as a human carcinogen
(Cogliano et al., 2004). When administered to
rodents, NNK elicits both adenoma and adenocarci-
noma of the lung (Hoffmann & Hoffmann, 1997).
The other major cigarette smoke carcinogens, poly-
cyclic aromatic hydrocarbons such as BaP, induce
predominantly squamous cell carcinoma of the lung
(Hoffmann & Hoffmann, 1997; Stellman, Muscat,
Thompson, Hoffmann, & Wynder, 1997).
Concentrations of BaP and NNK in cigarette smoke
taken by mouth varied in test subgroups of the
present study. Among European Americans, the
concentrations of BaP and NNK were higher in
smoke taken in by men than by women; we found no
significant gender differences in concentration of
select carcinogens in smoke taken in by African
Americans. Cigarette smoke taken in by African
Americans men had significantly higher concentra-
tion of BaP (44.5 pg/ml smoke) than did smoke taken
in by European American men (36.6 pg/ml smoke),
p5.002. Similarly, BaP in smoke taken in was
41.6 pg/ml smoke for African American women,
versus 35.2 pg/ml smoke for European American
women (p5.014). Whether the composition of
cigarette smoke constituents plays any role with
respect to the observed gender differences in histo-
logic types of lung cancer among smokers remains to
be explored further.
In conclusion, the present study shows that
emissions (yields) of mainstream smoke carcinogens
from cigarettes smoked by women are somewhat
lower than those from cigarettes smoked by men.
These differences are significant in European
Americans. Thus gender differences in exposure to
tobacco smoke carcinogens cannot account for a
higher risk of lung cancer in women than men.
Compared with women, exposure may be under-
estimated in men using conventional markers such as
cigarettes per day or pack-years. The actual dose of
carcinogen exposure, gender differences, and the
presence of menthol in cigarettes also influence
the metabolism of carcinogens, which may affect
the development of disease. This topic is not
addressed in this paper.
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